Related Experiment Video

Updated: Oct 29, 2025

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
04:01

Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics

Published on: March 15, 2024

1.3K

Ferroptosis Holds Novel Promise in Treatment of Cancer Mediated by Non-coding RNAs

Yuan Zhi1,2, Ling Gao3,4, Baisheng Wang5

  • 1Department of Oral and Maxillofacial Surgery, The Second Xiangya Hospital, Central South University, Changsha, China.

Frontiers in Cell and Developmental Biology
|July 8, 2021
PubMed

Insights

Ferroptosis, a cell death form linked to iron and oxidative stress, can eliminate cancer cells. This review highlights circular RNAs (circRNAs) as key regulators of ferroptosis and carcinogenesis, offering new therapeutic avenues.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Ferroptosis is a regulated cell death pathway involving iron metabolism and oxidative stress.
  • It selectively eliminates cancer cells through molecular regulation.
  • Non-coding RNAs (ncRNAs), particularly microRNAs (miRNAs), are known regulators, but circular RNAs (circRNAs) roles are less explored.

Purpose of the Study:

  • To review the molecular mechanisms of ferroptosis.
  • To highlight the regulatory role of circRNAs in ferroptosis and cancer.
  • To discuss the therapeutic potential of ferroptosis in cancer treatment.

Main Methods:

  • Literature review of ferroptosis regulation.
  • Analysis of circRNA functions in cell death pathways.
  • Discussion of circRNAs' impact on carcinogenesis.

Main Results:

  • CircRNAs play a significant role in controlling ferroptosis.
  • CircRNAs influence cancer development and progression.
  • Understanding circRNA-mediated ferroptosis offers novel therapeutic strategies.

Conclusions:

  • CircRNAs are crucial regulators of ferroptosis and carcinogenesis.
  • Targeting circRNAs in ferroptosis pathways holds promise for cancer therapy.
  • Further research into circRNAs will advance cancer treatment and prognosis prediction.
Keywords:
cancer therapycircRNAsferroptosislipid peroxidationmiRNAsmultiple drug resistance

More Related Videos

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells11:11

Desthiobiotin-Streptavidin-Affinity Mediated Purification of RNA-Interacting Proteins in Mesothelioma Cells

Published on: April 25, 2018

8.4K
Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells07:23

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells

Published on: May 30, 2025

795

Related Concept Videos

Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.6K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.3K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
22.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.0K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.2K
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
5.3K